Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Lucknow, UP, India.
Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Saudi Arabia.
Drug Discov Today. 2022 Sep;27(9):2415-2424. doi: 10.1016/j.drudis.2022.06.003. Epub 2022 Jun 11.
Ionic liquids (ILs) are widely used as solvents, co-solvents and permeation enhancers in the biomedical and pharmaceutical fields. There are many advantages to using active pharmaceutical ingredients (APIs) in the production of ILs for drug delivery, including the ability to tailor solubility, improve thermal stability, increase dissolution, regulate drug release, improve API permeability, and modulate cytotoxicity on tumor cells. Such an approach has shown significant potential as a tool for drug delivery. As a result, APIs converted into ILs are used as active components in solutions, emulsions, and even nanoparticles (NPs). In this review, we explore the use and physiochemical characteristics of APIs via ILs, including improvements of their physicochemical properties in preformulation and formulation development.
离子液体 (ILs) 在生物医药和制药领域被广泛用作溶剂、共溶剂和渗透增强剂。在药物传递中使用活性药物成分 (API) 生产 ILs 有许多优点,包括能够定制溶解度、提高热稳定性、增加溶解、调节药物释放、提高 API 渗透性以及调节对肿瘤细胞的细胞毒性。这种方法作为药物传递工具显示出了巨大的潜力。因此,转化为 ILs 的 API 被用作溶液、乳液,甚至纳米颗粒 (NPs) 中的活性成分。在本综述中,我们探讨了通过 ILs 对 API 的使用和物理化学特性,包括改善其在制剂前和制剂开发中的物理化学性质。
J Control Release. 2021-10-10
Int J Mol Sci. 2020-11-5
Drug Discov Today. 2020-5
Pharm Res. 2022-10
Expert Opin Drug Deliv. 2013-6-25
AAPS PharmSciTech. 2025-1-8
Int J Mol Sci. 2023-5-16
Int J Mol Sci. 2023-5-9
Pharmaceutics. 2023-2-20